(DGICA) Donegal - Overview
Sector: Financial ServicesIndustry: Insurance - Property & Casualty | Exchange NASDAQ (USA) | Currency USD | Market Cap: 637m | Total Return -8.6% in 12m
Stock: Insurance, Property, Casualty, Liability, Auto
| Risk 5d forecast | |
|---|---|
| Volatility | 25.2% |
| Relative Tail Risk | -7.53% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.40 |
| Alpha | -12.57 |
| Character TTM | |
|---|---|
| Beta | 0.188 |
| Beta Downside | 0.509 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.56% |
| CAGR/Max DD | 0.41 |
EPS (Earnings per Share)
Revenue
Description: DGICA Donegal March 03, 2026
Donegal Group Inc. (NASDAQ: DGICA), a subsidiary of Donegal Mutual Insurance Company, is an insurance holding company offering commercial and personal lines of property and casualty insurance through its Investment Function, Commercial Lines, and Personal Lines segments. It provides coverages such as commercial automobile liability, business property protection, workers compensation benefits, private passenger auto insurance, and homeowners policies against perils like fire, windstorm, and theft, marketed via independent agents in Mid-Atlantic, Midwest, Southern, and Southwestern states.
In the **Property & Casualty Insurance** sub-industry, Donegal focuses on underwriting discipline to manage risks from auto accidents, property damage, and employee injuries, operating as a regional player since its 1986 incorporation in Marietta, Pennsylvania.[1][overview]
For deeper insights into DGICAs valuation, check ValueRay as part of your research.
Headlines to watch out for
- Catastrophe losses significantly impact underwriting profitability
- Investment portfolio performance drives non-underwriting income
- Premium growth in commercial lines boosts revenue
- Regulatory changes in insurance pricing affect profitability
- Independent agent network efficiency influences policy sales
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 79.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.05 > 1.0 |
| NWC/Revenue: -4.84k% < 20% (prev 115.8%; Δ -4.96k% < -1%) |
| CFO/TA 0.03 > 3% & CFO 70.2m > Net Income 79.3m |
| Net Debt (8.21m) to EBITDA (101.6m): 0.08 < 3 |
| Current Ratio: 0.00 > 1.5 & < 3 |
| Outstanding Shares: last quarter (31.8m) vs 12m ago -3.97% < -2% |
| Gross Margin: 30.47% > 18% (prev 0.23%; Δ 3.02k% > 0.5%) |
| Asset Turnover: 41.43% > 50% (prev 42.36%; Δ -0.93% > 0%) |
| Interest Coverage Ratio: 57.47 > 6 (EBITDA TTM 101.6m / Interest Expense TTM 1.35m) |
Altman Z'' -15.00
| A: -19.84 (Total Current Assets 26.8m - Total Current Liabilities 47.38b) / Total Assets 2.39b |
| B: 0.12 (Retained Earnings 297.7m / Total Assets 2.39b) |
| C: 0.03 (EBIT TTM 77.6m / Avg Total Assets 2.36b) |
| D: 0.17 (Book Value of Equity 289.8m / Total Liabilities 1.75b) |
| Altman-Z'' Score: -129.4 = D |
Beneish M -3.23
| DSRI: 0.30 (Receivables 180.8m/610.3m, Revenue 978.4m/989.6m) |
| GMI: 0.75 (GM 30.47% / 22.75%) |
| AQI: 2.01 (AQ_t 0.99 / AQ_t-1 0.49) |
| SGI: 0.99 (Revenue 978.4m / 989.6m) |
| TATA: 0.00 (NI 79.3m - CFO 70.2m) / TA 2.39b) |
| Beneish M-Score: -3.23 (Cap -4..+1) = AA |
What is the price of DGICA shares?
Over the past week, the price has changed by -0.24%, over one month by -4.48%, over three months by -15.71% and over the past year by -8.61%.
Is DGICA a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DGICA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.8 | 23.3% |
| Analysts Target Price | 20.8 | 23.3% |
DGICA Fundamental Data Overview March 25, 2026
P/E Forward = 16.0
P/S = 0.6511
P/B = 0.9739
P/EG = 1.3809
Revenue TTM = 978.4m USD
EBIT TTM = 77.6m USD
EBITDA TTM = 101.6m USD
Long Term Debt = unknown (0.0)
Short Term Debt = 35.0m USD (from shortTermDebt, last quarter)
Debt = 35.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.21m USD (from netDebt column, last quarter)
Enterprise Value = 150.7m USD (636.8m + Debt 35.0m - CCE 521.2m)
Interest Coverage Ratio = 57.47 (Ebit TTM 77.6m / Interest Expense TTM 1.35m)
EV/FCF = 2.15x (Enterprise Value 150.7m / FCF TTM 70.2m)
FCF Yield = 46.60% (FCF TTM 70.2m / Enterprise Value 150.7m)
FCF Margin = 7.18% (FCF TTM 70.2m / Revenue TTM 978.4m)
Net Margin = 8.11% (Net Income TTM 79.3m / Revenue TTM 978.4m)
Gross Margin = 30.47% ((Revenue TTM 978.4m - Cost of Revenue TTM 680.3m) / Revenue TTM)
Gross Margin QoQ = 42.26% (prev 26.83%)
Tobins Q-Ratio = 0.06 (Enterprise Value 150.7m / Total Assets 2.39b)
Interest Expense / Debt = 0.97% (Interest Expense 341k / Debt 35.0m)
Taxrate = 17.98% (3.77m / 21.0m)
NOPAT = 63.7m (EBIT 77.6m * (1 - 17.98%))
Current Ratio = 0.00 (Total Current Assets 26.8m / Total Current Liabilities 47.38b)
Debt / Equity = 0.05 (Debt 35.0m / totalStockholderEquity, last quarter 640.4m)
Debt / EBITDA = 0.08 (Net Debt 8.21m / EBITDA 101.6m)
Debt / FCF = 0.12 (Net Debt 8.21m / FCF TTM 70.2m)
Total Stockholder Equity = 614.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.36% (Net Income 79.3m / Total Assets 2.39b)
RoE = 12.91% (Net Income TTM 79.3m / Total Stockholder Equity 614.6m)
RoCE = 12.63% (EBIT 77.6m / Capital Employed (Equity 614.6m + L.T.Debt 0.0))
RoIC = 9.80% (NOPAT 63.7m / Invested Capital 649.6m)
WACC = 6.34% (E(636.8m)/V(671.8m) * Re(6.64%) + D(35.0m)/V(671.8m) * Rd(0.97%) * (1-Tc(0.18)))
Discount Rate = 6.64% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -100.0 | Cagr: -2.34%
[DCF] Terminal Value 84.54% ; FCFF base≈69.1m ; Y1≈66.5m ; Y5≈65.5m
[DCF] Fair Price = 55.73 (EV 1.76b - Net Debt 8.21m = Equity 1.75b / Shares 31.4m; r=6.34% [WACC]; 5y FCF grow -4.97% → 3.0% )
EPS Correlation: 66.38 | EPS CAGR: 4.10% | SUE: 0.23 | # QB: 0
Revenue Correlation: 87.80 | Revenue CAGR: 3.96% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.38 | Chg7d=+0.000 | Chg30d=-0.010 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=2.10 | Chg7d=+0.050 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=-3.2% | Growth Revenue=+0.0%
EPS next Year (2027-12-31): EPS=2.10 | Chg7d=+0.150 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+0.0% | Growth Revenue=+4.2%